Cohort research resourceUK Biobank · NHANES

UK Biobank + NHANES cohort evidence

Weekly recurrence of sustained MVPA in adults with type 2 diabetes

An interactive research resource for examining how sustained MVPA recurs across the week and how this pattern relates to mortality and cardiovascular outcomes.

T2D participants
3,419
Independent cohorts
2
All-cause deaths
423
Featured result · UK Biobank

All-cause mortality

Hazard ratio
0.250.500.751.0001.22.33.54.75.870 days/week: HR 1.001.17 days/week: HR 0.712.33 days/week: HR 0.523.5 days/week: HR 0.614.67 days/week: HR 0.415.83 days/week: HR 0.347 days/week: HR 0.47
Reference: 0 qualifying daysOverall P = 0.002

Primary exposure

Standardized weekly recurrence

Qualifying day
≥2 sustained MVPA boutseach bout ≥5 min
Weekly recurrence
7 × Q / V0–7 equivalent qualifying days/week
Qqualifying valid daysVobserved valid days

Standardized to seven valid days; this is not a reconstructed calendar week. Weekdays and weekend days use the same criterion.

Evidence explorer

Browse the research atlas

Each section presents a defined analytical layer rather than an individual risk prediction.

Analytic foundation

Cohorts represented

Analyses were performed separately in each cohort; estimates are displayed side by side and are not pooled.

UKB
UK Biobank2,440 adults with T2D
Median follow-up
10.2 years
All-cause deaths
289
NH
NHANES 2011–2014979 adults with T2D
Median follow-up
6.7 years
All-cause deaths
134

The atlas reports cohort-level associations. It does not establish causality, estimate individual risk or recommend a clinical activity dose.